Featured Articles

Royal Philips which is a global leader in health technology claimed health economic results from DEFINE FLAIR clinical trial comparing cost-effectiveness between instant wave-free ratio…
Read More...

The Janssen Pharmaceutical Companies of Johnson and Johnson announced results of new analysis exhibiting that INVOKANA remarkably lessened the risk of cardiovascular death or…
Read More...

Eyenuk which is a leading developer of advanced artificial intelligence enabled clinically supported solutions to identify diseases via retinal image analysis declared that it has…
Read More...

TherapeuticsMD which is an innovative women's healthcare company claimed the FDA's admission of NDA for TX-001HR. TX-001HR is the company’s investigational bio-identical hormone therapy…
Read More...

Tyber Medical which is a privately held company emphasizing on developing breakthrough medical devices for private label opportunities and facilitating  the science  of bioengineered…
Read More...

Roche declared that its new hematology testing solution, the cobas m 511 integrated hematology analyzer has received 510(k) clearance from the U.S Food and Drug Administration. The…
Read More...

According to the newly published research in Molecular and Cellular Proteomics describes a biomarker panel based on patient IgM antibodies that can certainly distinguish between Zika…
Read More...

Biotech company based in Dayton,OH has received IRB approval to initiate a Clinical case series studying spinal cord stimulator alogrithms in patients afflicted with back pain.…
Read More...

CrossRoads Extremity Systems which is privately held medical device company offering innovative foot & ankle fixation implant systems and services asserted that it has recently…
Read More...

Leica Biosystems declared the release of a remarkable update to the highly regarded BOND-III IHC and ISH stainer. The latest advance to the BOND-III stainer incorporates a unique set…
Read More...

Orthofix International declared the U.S. Food and Drug Administration (FDA) and European CE Mark approvals for its next-generation PhysioStim bone growth stimulators. The PhysiStim…
Read More...

Premier Biotech was awarded a 510 (k) clearance for the following drugs Amphetamine, Cocaine, Marijuana, Methamphetamine, Opiates and Phencyclidine from the Food and Drug Administration…
Read More...

Zydus Cadila which is a leading innovation-driven, global healthcare provider asserted that it has entered into a definitive agreement with Medicure International which is subsidiary of…
Read More...

MyBiotics Pharma which is a microbiome therapeutics company announced that it has entered into second option agreement with Ferring Holding Ltd. for the validation of MyBiotics'…
Read More...

Global pharmaceutical company, Glenmark affirmed poster presentations of data from clinical studies of Ryaltris which is an investigational fixed-dose combination nasal spray for…
Read More...

Biogen and Abbvie asserted voluntary worldwide withdrawal of ZINBRYTA for relapsing multiple sclerosis. Taking into account the limited number of patients who are being treated,…
Read More...

Ionis Pharmaceuticals which is a leader in antisense therapeutics asserted that the positive top-line data from a completed Phase 1/2 study of IONIS-HTTRx      in people with early…
Read More...

Ageless Forever asserts to offer GAINSWave which is an innovative noninvasive medical therapy that utilizes low-intensity shockwave therapy to treat Erectile Dysfunction symptoms. It…
Read More...

Regeneron Pharmaceuticals and Sanofi claimed that the U.S Food and Drug Administration has considered to assess the supplemental Biologics License Application (sBLA) of DUPIXENT as an…
Read More...

Jazz Pharmaceuticals affirmed that the U.S Food and Drug Administration has conceded for filing with standard review the company's New Drug Application requesting marketing approval for…
Read More...